Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry
Author links open overlay panel,
,
,
,
,
,
,
,
Highlights
- •
Understanding uncertainty in the COVID-19 pandemic is a priority for the industry.
- •
Policy and population behavioral affect risk management in the short/mid-term.
- •
Information around natural history unknowns will guide long-term risk management.
- •
Our framework allows risk management and risk-sharing strategies discussions.
© 2020 The Author(s). Published by Elsevier Ltd.